Thermo Fisher Sweetens Qiagen Takeover Bid To $12.5B
Citing Qiagen's strong performance during the coronavirus pandemic, Thermo Fisher Scientific said in a joint release Thursday that it has increased its takeover bid for the European genetic testing company from...To view the full article, register now.
Already a subscriber? Click here to view full article